---
title: "Hydralazine - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db01275-mesh-d006973-1.html
toc: false 
---


Path ID: `DB01275_MESH_D006973_1`
{% include image.html url="images/db01275-mesh-d006973-1.png" file="db01275-mesh-d006973-1.png" alt="db01275-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D006830 | hydralazine | Drug |
| GO:0048763 | calcium-induced calcium release activity | MolecularActivity |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| HP:0032263 | Increased blood pressure | PhenotypicFeature |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Hydralazine | NEGATIVELY REGULATES | Calcium-Induced Calcium Release Activity |
| Calcium-Induced Calcium Release Activity | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01275](https://go.drugbank.com/drugs/DB01275)
